MedPath

AVACEN Treatment Method and Postprandial Blood Glucose

Not Applicable
Completed
Conditions
Postprandial Hyperglycemia
Registration Number
NCT04018976
Lead Sponsor
San Diego State University
Brief Summary

A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on postprandial blood glucose. The AVACEN device creates negative pressure around the hand while heating the palm. Two sham devices, one providing heat but no vacuum and one providing neither heat nor vacuum were also used. Each subject will use each of these three devices during the first hour of a 2-hour oral glucose tolerance test on separate visits. Subjects arrived in the morning following an overnight fast. Fasting blood glucose, blood pressure, tympanic temperature, and subjective thermal ratings were measured before and throughout the 2-hour oral glucose tolerance test.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • Healthy individuals
Exclusion Criteria
  • Diagnosis of diabetes, diabetes medication, hypertension medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Postprandial Blood Glucose30 minutes

Measuring peak postprandial blood glucose with Contour Next glucometer

Secondary Outcome Measures
NameTimeMethod
Tympanic Temperature30 minutes

Measuring tympanic temperature with infrared thermometer

ASHRAE 7 point thermal sensation scale30 minutes

Measuring subjective temperature with thermal sensation scale

Blood Pressure30 minutes

Measuring blood pressure with automated cuff

Trial Locations

Locations (1)

Jeff Moore

🇺🇸

San Diego, California, United States

Jeff Moore
🇺🇸San Diego, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.